Sorry sanddollar, your 2006 data regarding older generation ValiMed applications (when Jim Griffin, President and CEO of CDEX Inc was in power years ago) pales in the shining light of MULTIPLE SUCCESSES ValiMed HAS ACHIEVED since those years ago.
In due course, ValiMed capabilities expanded significantly with an ever growing signature library, reporting capabilities, etc. ValiMed has continually improved. It now seems to boast a much smaller size and boasts other improvements that seem to meet the needs of many respected and influential hospitals. Read the ValiMed newsletter on the CDEX site for even MORE aspects to consider.
And CDEX? The company has very recently grown in impressive fashion, plus is expanding the applications in exciting areas with the Meth Scanner being endorsed by multiple law enforcement organizations plus introducing a narcotics product based upon the ValiMed platform!!
Relax and watch what unfolds in due course. You seem tense. You don't seem to enjoy reading the CDEX information being provided. Really, just relax and watch what unfolds (in due course).
Consider how long we waited to see the very first independent peer-reviewed study published, which I believed was based fully on Gen-1 equipment. This was published AFTER 2006.
Consider the impressive organizations that have chosen ValiMed AFTER your 2006 news with ex-CEO Griffin.
Consider the very recently growing list of ValiMed facilities
University of Michigan Health System (Ann Arbor, Michigan) Children’s Medical Center of Dallas (Dallas Texas) Cedars-Sinai Medical Center (Los Angeles, California) Cleveland Clinic Foundation (Cleveland, Ohio) Henry Ford Health System (Detroit, Michigan) Primary Children’s Medical Center (Salt Lake City, Utah) Vall d’Hebron Hospital (Barcelona Spain) Stanford Hospitals and Clinics (Stanford, California) All Children’s Hospital, Inc. (St. Petersburg, Florida) Tucson Medical Center (Tucson, AZ) Loyola University Medical Center (Maywood, Illinois) U.C. Davis Health System (Sacramento, California) University of Maryland Medical Center (Baltimore, Maryland) University of Utah Hospitals and Clinics (Salt Lake City, Utah) Veterans Administration Hospital (Palo Alto, California) Children's Hospital of The King's Daughters (Norfolk, VA) Mission Health System (Asheville, NC) Tawam Hospital (Al Ain, United Arab Emirates) South Shore Hospital (South Weymouth, MA) Children’s Hospitals and Clinics of Minnesota (Minneapolis, Minnesota) Children’s Hospitals and Clinics of Minnesota (St. Paul, Minnesota) Mount Carmel Health System (Columbus, Ohio) Integris Southwest Medical Center (Oklahoma City, OK) Bronson Methodist Hospital (Kalamazoo, MI) East Jefferson General Hospital (Metairie, LA) St. Joseph Mercy Hospital (Ypsilanti, MI) Imperial College Healthcare, NHS Trust, Charing Cross (London, UK) Imperial College Healthcare, NHS Trust, Hammersmith (London, UK) Lakeland Regional Medical Center (Lakeland, FL)
CDEX Inc. (OTCBB: CEXI) announces record ValiMed sales and more than doubling of its hospital client base in FY08, which ended October 31, with eleven ValiMed units sold or leased in the fourth quarter and, in addition, a backlog of orders. Going into FY09 with a backlog and a strong sales pipeline, CDEX projects that in the first six months of FY09 it will sell or lease over 25 new ValiMed units, continuing the trend of year-over-year growth.
CDEX Inc. CEO Concludes Successful European Tour of ValiMed(TM) Distributors and Partnering Hospitals 13/10/2008
November 6, 2008 — CDEX INC. ANNOUNCES RECORD FY08 VALIMEDTM SALES/LEASES AND FORECASTS CONTINUED GROWTH IN FY09
October 13, 2008 — CDEX INC CEO CONCLUDES SUCCESSFUL EUROPEAN TOUR OF VALIMED™ DISTRIBUTORS AND PARTNERING HOSPITALS
September 23, 2008 — ValiMed™ Targets Hospital Pharmacists in France
September 15, 2008 — ValiMed™ Model CCT Receives Clean Bill of Health from TUV Rheinland of North America, Inc.; CDEX is Authorized to use TUV Mark
All of this has transpired in due course. We will know much more, in due course.
On November 6, 2008, CDEX announced record ValiMed sales and a more than doubling of its hospital client base in FY08, which ended October 31. Eleven ValiMed units were sold or leased in the fourth quarter and, in addition, a backlog of orders exists. Going into FY09 with a backlog and a strong sales pipeline, CDEX projected that in the first six months of FY09 it will sell or lease over 25 new ValiMed units, continuing the trend of year-over-year growth. CDEX further announced the introduction of the next generation of ValiMed systems at the upcoming American Society of Health-System Pharmacists meeting in Orlando, Florida, in December. These new models and applications are flexible and designed to accommodate the varying requirements of CDEX customers worldwide. CDEX also anticipates that its strong U.S. sales pipeline should result in continued growth of the market share and branding of ValiMed as a standard of medication safety. CDEX further expects that its international expansion should continue in FY09 with the addition of new distributor geographies and opportunities related to co-development and marketing initiatives with key partners in Europe to customize its medication signatures offering for the ValiMed Systems. CDEX believes that it will sell more ValiMed Units in the first six months of the new fiscal year than in all of FY08.
I will continue to monitor this SEC web-site for CDEX filings. I am sure to learn evern MORE exciting things, in due course. Please join me in a relaxing adventure sanddollar, moving into the successful future... in due course of course.
Grifols came in due course, long AFTER 2006. In fact.... 15/04/2008 is one date to consider.
Grifols signs a new distribution agreement with CDEX for Spain, Portugal and Italy 15/04/2008
Grifols has signed a distribution agreement with the US company CDEX, manufacturer of Valimed, an identification system for intravenous medications. The agreement includes the territories of Spain, Portugal and Italy.
Valimed is a step forward in pharmaceutical validations and is a perfect complement to our Oncotools line, offering the hospital pharmacist even more tools to facilitate their daily tasks and increase safety in the medication cycle in hospitals.
News 
Market Data 
Discover 
